March 11, 2025 - 03:42

BOSTON & MONTREAL, March 10, 2025 -- enGene Holdings Inc., a clinical-stage company specializing in non-viral genetic medicines, has reported its financial results for the first quarter ending January 31, 2025. The company is focused on advancing innovative therapies aimed at treating various diseases through its proprietary genetic medicine platform.
In the financial report, enGene highlighted key metrics that reflect its ongoing commitment to research and development in the genetic medicine field. The company continues to invest in its pipeline of product candidates, which are designed to address unmet medical needs. The management team expressed optimism about the progress made during the quarter and reaffirmed its strategic goals moving forward.
Additionally, enGene provided insights into its operational achievements and future plans. The company remains dedicated to enhancing its capabilities and expanding its footprint in the genetic medicine landscape, aiming to deliver transformative solutions to patients worldwide.
February 24, 2026 - 21:58
Mpls Fed survey: Upper Midwest businesses report falling profits, tariff uncertaintyA recent survey conducted by the Federal Reserve Bank of Minneapolis reveals a concerning trend of falling profits across the Ninth District, which encompasses the Upper Midwest. Businesses from...
February 24, 2026 - 05:04
Widespread boil water advisory prompts businesses to closeA major boil water advisory has swept through the city, leading to the immediate closure of numerous restaurants, cafes, and other businesses reliant on safe tap water. City officials confirmed the...
February 23, 2026 - 18:50
NYC mayor threatens property tax hike, raising concerns for businessesA proposed property tax hike from New York City`s mayor is generating significant concern among the city`s business community. The initiative, aimed at addressing a substantial budget shortfall,...
February 23, 2026 - 12:25
Media Buying Briefing: Dentsu’s new CEO on how he’s going to grow the business againTakeshi Sano has assumed the role of global CEO at Dentsu, signaling a strategic shift for the advertising holding company. Sano brings a distinctly more outgoing and worldly approach to leadership...